President Trump has signed an executive action intended to reduce the cost of prescription drugs for Americans. The initiative aims to strengthen Medicare's bargaining power for drug prices and correct legislative gaps that currently benefit certain drugs over others. Key changes may include increasing transparency regarding pharmacy benefit managers. In a separate development, Trump threatens to revoke Harvard University's tax-exempt status following federal funding cuts triggered by the university’s noncompliance with administration demands, raising significant concerns among college leaders about the potential implications.
President Trump's recent executive action aims to lower prescription drug prices, with a focus on enhancing Medicare's negotiating power and correcting existing legislative flaws.
The White House plans to increase transparency around pharmacy benefit managers' compensation, which is part of a broader strategy to address prescription drug costs.
#prescription-drug-prices #medicare #trump-administration #higher-education-policy #transparency-in-healthcare
Collection
[
|
...
]